Amyloidosis UK
a) providing information, support and advice to people living with the Condition, their families and carers; b) advocating to ensure that every person has timely and effective diagnosis, treatment and care of the Condition;c) working closely with all stakeholders to facilitate the availability of effective treatments for the Condition. d) funding and supporting research to advance scientif
Objects
THE OBJECTS OF THE CIO ARE THE RELIEF OF SICKNESS AND THE PRESERVATION AND PROTECTION OF GOOD HEALTH AMONG PEOPLE IN THE UNITED KINGDOM LIVING WITH THE MEDICAL CONDITION ATTR AMYLOIDOSIS (KNOWN AS THE ‘CONDITION’) IN PARTICULAR BUT NOT EXCLUSIVELY BY:A) PROVIDING INFORMATION, SUPPORT AND ADVICE TO PEOPLE LIVING WITH THE CONDITION, THEIR FAMILIES AND CARERS;B) ADVOCATING TO ENSURE THAT EVERY PERSON HAS TIMELY AND EFFECTIVE DIAGNOSIS, TREATMENT AND CARE OF THE CONDITION;C) WORKING CLOSELY WITH ALL STAKEHOLDERS TO FACILITATE THE AVAILABILITY OF EFFECTIVE TREATMENTS FOR THE CONDITION.D) FUNDING AND SUPPORTING RESEARCH TO ADVANCE SCIENTIFIC UNDERSTANDING OF THE CONDITION AND ITS EFFECTIVE TREATMENT AND TO PUBLISH THE USEFUL RESULTS THEREOF FOR THE PUBLIC BENEFIT.
Financial health, per its FY2025 accounts
The accounts state that Amyloidosis UK generated total income of £105,228 and incurred total expenditure of £52,485, resulting in a surplus of £52,742 for the year ending 31/03/2025. The bank balance at year-end was £73,866.46, with no difference from the bank statement. The independent examiner confirmed that no material matters came to their attention that would cause them to believe the accounts were not prepared in accordance with the Charities Act 2011.
What the accounts disclose
Policies the charity declares
- Complaints handling
- Conflicting interests
- Trustee expenses policy and procedures
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 31/03/2025
- Volunteers: 1
Self-declared on the annual return for the financial year ending 31/03/2024
- Volunteers: 2
Self-declared on the annual return for the financial year ending 31/03/2023
- Volunteers: 1
Trustees
- CARLOS HERAS-PALOU
- David Gregory
- Julian Robert Macleod
- Ruth Eleanor Bramwell
- Vincent Graham Nesan Nicholas
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £105k | £54k |
| 31/03/2024 | £2k | £18k |
| 31/03/2023 | £4k | £16k |
| 31/03/2022 | £33k | £31k |
| 31/03/2021 | £31k | £10k |
Common questions
Is Amyloidosis UK financially healthy?
Per its FY2025 accounts: The accounts state that Amyloidosis UK generated total income of £105,228 and incurred total expenditure of £52,485, resulting in a surplus of £52,742 for the year ending 31/03/2025. The bank balance at year-end was £73,866.46, with no difference from the bank statement. The independent examiner confirmed that no material matters came to their attention that would cause them to believe the accounts were not prepared in accordance with the Charities Act 2011. Its FY2025 accounts were independently examined.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| The Squire Patton Boggs Charitable Trust | 2 | £1k |
| CECIL PILKINGTON CHARITABLE TRUST | 1 | £14k |
| THE ORR MACKINTOSH FOUNDATION LIMITED | 1 | £10k |
| THE CYRIL AND EVE JUMBO CHARITABLE TRUST | 1 | £8k |
| PILKINGTON CHARITIES FUND | 1 | £7k |
| THE ROGER AND JEAN JEFCOATE TRUST | 1 | £6k |
| THE BATCHWORTH TRUST | 1 | £5k |
| WHITAKER CHARITABLE TRUST | 1 | £3k |
Charities like this
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| Amyloidosis UK | £105k | — | 0 | unclear | — | no doubt |
| MYOSITIS UK | £140k | — | 0 | unclear | — | no doubt |
| SARCOIDOSISUK | £185k | — | 0 | unclear | — | no doubt |
| THYROID UK | £103k | — | 0 | above | — | no doubt |
| ENDOMETRIOSIS UK | £1.5m | — | — | unclear | — | no doubt |
| MLD UK | £28k | — | 0 | unclear | — | no doubt |